MUSCLE-INVASIVE BLADDER CANCER
Clinical trials for MUSCLE-INVASIVE BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new MUSCLE-INVASIVE BLADDER CANCER trials appear
Sign up with your email to follow new studies for MUSCLE-INVASIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental bladder cancer drug shows promise but trial halted early
Disease control TerminatedThis study tested an experimental drug called enfortumab vedotin, alone or with other cancer drugs, in people with advanced bladder or urinary tract cancer. The goal was to see if the drug could shrink tumors and control the disease. The trial included 348 participants but was te…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New combo therapy shows promise for tough bladder cancer
Disease control TerminatedThis study tested whether adding the immunotherapy drug avelumab to standard radiation could help treat muscle-invasive bladder cancer in patients who cannot receive the usual chemotherapy. Fourteen participants received the combination therapy. The goal was to see if the cancer …
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can a simple urine test replace tumor biopsies for bladder cancer treatment?
Knowledge-focused TerminatedThis study looked at whether genetic changes found in urine could match those in tumor tissue for people with high-risk non-muscle invasive bladder cancer. The goal was to see if a urine test could help doctors choose the best immunotherapy for each patient. The study planned to …
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Sponsor: Hopital Foch • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC